Joint Formulary & PAD

Olanzapine - Nausea and vomiting (palliative care)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oro-dispersible
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
 

Status 2

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important

Off-label use.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Olanzapine
Indication :
Nausea and vomiting (palliative care)
Group Name :
Keywords :
Brand Names Include :
Important Information :

Off-label use. Primary care prescribing on request of specialist palliative care team.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Olanzapine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Nausea and vomiting (palliative care).

Committee Recommendations (0)

  • No records returned.